Improved Academic Performance and Medication Rebound in Patients with ADHD Following the Use of Vayarin®, a Multi- Year, Real-World Retrospective Study

New Retrospective Study to be Presented at The American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting January 13-15, 2017 in Washington DC BALTIMORE, Jan. 10, 2017 (GLOBE NEWSWIRE) — Up to 75 percent of individuals with Attention Deficit Hyperactivity Disorder (ADHD) experience emotional dysregulation, according to Research in Developmental Disabilities. Emotional dysregulation […]

VAYA Pharma CEO featured in Baltimore Business Journal

VAYA Pharma’s CEO Rob Crim spent five minutes with the Baltimore Business Journal digital editor, Jonathan Munshaw, to share information about VAYA Pharma’s products, the company’s growth and his daily responsibilities.  Currently, the majority of Rob’s time is focused on stimulating awareness of the company’s products – Vayarin, Vayacog and Vayarol – among patients and […]

Rob Crim featured on WYPR’s “Why Baltimore”

VAYA Pharma CEO Rob Crim was recently featured on WYPR’s “Why Baltimore,” hosted by Shannon Landwehr, President & CEO of the Economic Alliance of Greater Baltimore. In this segment, Rob discusses the reasons behind the company’s recent move to the University of Maryland BioPark, including Baltimore’s reputation for being a catalyst in innovation, proximity to […]

VAYA Pharma Appoints Director of Human Resources

BALTIMORE – October 3, 2016 – VAYA Pharma, a medical foods company and specialty division of Enzymotec Ltd., today announced the appointment of Niela Magwood-Phoenix as director of human resources. “Niela has a proven track record of success and leadership in human resources, and we are thrilled to have her join the team,” said Rob […]